1.00419
Parteck® M 200（甘露醇）
EMPROVE® ESSENTIAL, Ph. Eur., ChP, JP, USP, E 421
别名:
D-甘露醇
选择尺寸
关于此项目
产品名称
Parteck® M 200（甘露醇）, EMPROVE® ESSENTIAL, Ph. Eur., ChP, JP, USP, E 421
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
agency
BP
ChP
JP
Ph. Eur.
USP
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
The specification of the product is part of the Emprove® Material Qualification Dossier and can be found under "General Properties".
Features and Benefits
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Uniform doses with homogenous distribution
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Legal Information
存储类别
11 - Combustible Solids
wgk
WGK 1
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
This article describes the use of excipients to help address API stability issues.
This article describes the advantages of mannitol when used as an excipient in solid drug formulation.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持